Products
Applications
Company
Contact
EN
EN
- Global
CN
- 中国
menu
Close
Home
Products
System
Panels
Applications
Pharmacogenetics
Liquid Biopsy
Mutation Profiling
Hereditary Genetics
Methylation
Sample Integrity
Specimen Validity
Services
Assays by Agena
Certified Service Providers
Resources
Product Literature
Publication Library
Support
Service Plans
Distributors
Certified Service Providers
Company
Careers
Press
Contact
Customer Support Portal
Home
Products
System
Panels
Applications
Pharmacogenetics
Mutation Profiling
Liquid Biopsy
Hereditary Genetics
Methylation
Sample Integrity
Specimen Validity
Services
Assays by Agena
Certified Service Providers
Resources
Product Literature
Publication Library
Support
Service Plans
Distributors
Certified Service Providers
Company
Careers
Press
Contact
Customer Support Portal
Phone: (858) 882-2800
Home
/
Resources
/
Publication Library
Search Results for: Mutation Profiling
Search All publications
How recent?
Search
Prognostic value of preoperative von Willebrand factor plasma levels in patients with Glioblastoma
MassARRAY determination of somatic oncogenic mutations in solid tumors: moving forward to personalized medicine
Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non–small cell lung cancer patients
Implementation and Quality Control of Lung Cancer EGFR Genetic Testing by MALDI-TOF Mass Spectrometry in Taiwan Clinical Practice
The molecular profile of metastatic melanoma in Australia
Multiple and bilateral kidney tumors with clear cells of three different histotypes: A case report withclinicopathologic and molecular study
Testing ERBB2 p.L755S kinase domain mutation as a druggable target in a patient with advanced colorectal cancer
Mammary analogue secretory carcinoma: an evaluation of its clinicopathological and genetic characteristics
Phase II study of erlotinib plus tivantinib (ARQ 197) in patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer just after progression on EGFR-TKI, gefitinib or erlotinib
Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report
«
...
10
20
30
...
34
35
36
37
38
...
50
...
»